抗コクシジウム薬市場レポート：2031年までの動向、予測、競合分析

世界の抗コクシジウム薬市場の将来は、動物病院と小売薬局市場に機会がありそうです。世界の抗コクシジウム薬市場は、2025年から2031年にかけてCAGR 5.7%で成長すると予想されます。この市場の主な促進要因は、コクシジウム症の有病率の上昇、獣医学の発展、食肉および鶏肉製品の需要の拡大です。

• Lucintel社は、動物カテゴリーではコンパニオンアニマルが予測期間中も大きなセグメントであり続けると予測しています。
• 流通チャネルのカテゴリーでは、動物病院が予測期間中に最も高い成長を遂げると予想されます。
• 地域別では、北米が予測期間中に最も高い成長を遂げる見込みです。

抗コクシジウム薬市場の戦略的成長機会

抗コクシジウム薬市場は、タンパク質需要の増加により世界の家禽生産量の増加が続いていることから、大きな成長が見込まれています。このダイナミックな情勢は、業界関係者に数多くの戦略的機会を与えています。製剤の革新、持続可能な慣行へのシフト、動物福祉に対する消費者の意識の高まりが、市場力学を再構築しています。こうした動向を活用することで、企業は市場での地位を高め、進化する顧客ニーズに対応することができるため、戦略的成長機会を特定し追求することが不可欠となっています。

• 新興市場への進出：鶏肉生産が増加傾向にある新興市場には、大きな成長の可能性があります。企業は、東南アジアやアフリカなどの地域でパートナーシップや流通チャネルを模索し、抗コクシジウム薬に対する需要の増加を取り込むことで、売上と市場シェアを高めることができます。
• 新規製剤の開発：研究開発に投資して新規製剤を開発すれば、混雑した市場でも製品の差別化を図ることができます。革新的な送達システムや併用療法に注力することで、企業は有効性を高め、耐性を減らすことができ、コクシジウム症に対する高度な解決策を求める生産者に応えることができます。
• 予防衛生ソリューションへの注力：業界が予防衛生戦略へとシフトする中、全体的な管理プログラムに統合される抗コクシジウム剤は大きなチャンスをもたらします。コクシジウム症をターゲットとしながら、牛群全体の健康をサポートする製品を開発することで、包括的なソリューションを求める生産者を惹きつけることができます。
• テクノロジープロバイダーとのコラボレーション：テクノロジー企業とパートナーシップを結ぶことで、データに基づいた洞察や精密農業技術を通じて製品の提供を強化することができます。これらのテクノロジーを抗コクシジウムソリューションに統合することで、投与精度の向上や群れのモニタリングが可能となり、最終的に健康状態の改善と売上の増加につながります。
• 持続可能な製品開発：製品開発において持続可能性を重視することで、消費者の嗜好や規制上の要求に沿うことができます。環境に優しい植物由来の抗コクシジウム剤を開発することで、市場の関心を集めるだけでなく、企業を持続可能な農業のリーダーとして位置づけ、長期的な成長を促進することができます。

抗コクシジウム薬市場には、新興国市場への進出、新規製剤の開発、予防衛生ソリューションへの注力、技術プロバイダーとの提携、持続可能な製品開発など、いくつかの戦略的成長機会があります。これらの手段を追求することで、企業は競争力を強化し、進化する市場ニーズに対応し、急速に変化するこの業界で確固たる地位を確保することができます。

抗コクシジウム薬市場の促進要因・課題

抗コクシジウム薬市場は、生産慣行や消費者の需要に影響を与える様々な要因によって大きな変貌を遂げています。世界の家禽消費量の増加に伴い、コクシジウム症に対する効果的な解決策の必要性がますます高まっています。しかし、この市場は規制の圧力や消費者の嗜好の変化といった課題にも直面しています。利害関係者が、この進化する状況の複雑さを乗り切り、成長機会を活用するためには、促進要因と課題の両方を理解することが不可欠です。

抗コクシジウム薬市場を牽引する要因は以下の通りです：

• 養鶏生産の増加：鶏肉生産量の増加：鶏肉製品の需要増加は抗コクシジウム薬市場の主要な促進要因です。人口が増加し、食生活が高タンパク質消費にシフトするにつれて、養鶏業者は動物の健康と生産性を確保するための効果的な解決策を求め、抗コクシジウム剤の需要拡大につながります。
• 動物の健康に対する意識の高まり：消費者と生産者の間で、動物の福祉と健康に対する関心が高まっています。利害関係者は、人道的な農業慣行を確保しながら群れの健康と生産性を維持することを目指しているため、このような意識が効果的な抗コクシジウム薬の採用を後押ししています。
• 代替薬への規制支援：家畜への抗生物質使用に関する規制の強化は、代替抗コクシジウム剤の開発を促しています。この変化は、メーカーに新しいガイドラインに準拠した革新的なソリューションへの投資を促し、市場の成長をさらに促進しています。
• 技術の進歩：製剤とドラッグデリバリー・システムの革新により、抗コクシジウム剤の有効性が高まっています。研究開発と技術の進歩により、耐性を最小限に抑えた製品の開発が可能になり、効果的な治療を求める生産者にとって魅力的な製品となっています。
• 研究開発投資の増加：研究開発への注目の高まりが、抗コクシジウム薬市場の技術革新を促進しています。各社は新しい有効成分の発見や併用療法に投資しており、現在の需要を満たすだけでなく、将来に向けて競争力を高めています。

抗コクシジウム薬市場における課題は以下の通りです：

• 規制上の課題：規制状況の進化はメーカーにとって大きな課題です。厳しい安全性と有効性の基準への準拠は、製品開発のタイムラインを遅らせ、コストを増加させ、新製品の市場参入を複雑にします。
• 市場の飽和：市場が成長するにつれ、既存企業間の競争が激化し、市場が飽和状態に陥る可能性があります。この飽和状態によって価格が下落し、利益率が圧迫される可能性があるため、企業は持続的な成長を維持することが難しくなります。
• 消費者の嗜好の変化：オーガニック製品や抗生物質不使用製品に対する消費者の嗜好の変化は、従来の抗コクシジウム戦略を困難にする可能性があります。生産者はこのような嗜好に対応するため、新たな適合ソリューションへの投資が必要となります。

結論として、抗コクシジウム薬市場は、鶏肉生産の増加、動物の健康に対する意識の高まり、代替品に対する規制当局の支援、技術の進歩、研究開発への投資の増加によって牽引されています。しかし、規制上のハードル、市場の飽和、消費者の嗜好の変化といった課題に対処する必要があります。こうした力学を理解することは、利害関係者が市場の複雑さを乗り切り、成長機会をつかむのに役立つと思われます。

目次

第1章 エグゼクティブサマリー

第2章 世界の抗コクシジウム薬市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2019年から2031年までの市場動向と予測分析

• マクロ経済動向（2019-2024年）と予測（2025-2031年）
• 世界の抗コクシジウム薬市場の動向（2019-2024年）と予測（2025-2031年）
• 世界の抗コクシジウム薬市場：動物別
  • 家畜
  • ペット
• 世界の抗コクシジウム薬市場：薬効別
  • コクシジウム抑制
  • コクシジウム駆除
• 世界の抗コクシジウム薬市場：薬剤クラス別
  • イオンフォア
  • 抗生物質
  • スルホンアミド
  • 化学誘導体
  • その他
• 世界の抗コクシジウム薬市場：流通チャネル別
  • 動物病院
  • 小売薬局
  • その他

第4章 2019年から2031年までの市場動向と予測分析：地域別

• 地域別世界の抗コクシジウム薬市場
• 北米の抗コクシジウム薬市場
• 欧州の抗コクシジウム薬市場
• アジア太平洋地域の抗コクシジウム薬市場
• その他地域の抗コクシジウム薬市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 動物別世界：世界の抗コクシジウム薬市場の成長機会
  • 薬効別世界：世界の抗コクシジウム薬市場の成長機会
  • 薬剤クラス別：世界の抗コクシジウム薬市場の成長機会
  • 流通チャネル別：世界の抗コクシジウム薬市場の成長機会
  • 地域別：世界の抗コクシジウム薬市場の成長機会
• 世界の抗コクシジウム薬市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界の抗コクシジウム薬市場の生産能力拡大
  • 世界の抗コクシジウム薬市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Zoetis
• Phibro Animal Health Corporation
• Huvepharma
• Elanco
• Biochem Pharma
• Ceva
• Impextraco
• Virbac
• Boehringer Ingelheim International
• MSD Animal Health

The future of the global anticoccidial drug market looks promising with opportunities in the veterinary hospital and retail pharmacy markets. The global anticoccidial drug market is expected to grow with a CAGR of 5.7% from 2025 to 2031. The major drivers for this market are the rising prevalence of coccidiosis, growing developments in veterinary medicine, and expanding demand for meat and poultry products.

• Lucintel forecasts that, within the animal category, companion animals will remain a larger segment over the forecast period.
• Within the distribution channel category, veterinary hospital is expected to witness the highest growth over the forecast period.
• In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Anticoccidial Drug Market

The anticoccidial drug market is evolving rapidly, responding to the growing demand for poultry products and increasing concerns about drug resistance and animal welfare. Innovations in formulations and a shift toward sustainable practices are shaping this market. Regulatory changes and consumer preferences are also driving the development of alternative therapies and natural products. As stakeholders adapt to these challenges, several emerging trends are becoming prominent in the anticoccidial landscape.

• Shift to Natural Products: There is a notable shift toward natural and plant-based anticoccidials as consumers and producers alike seek alternatives to traditional chemical treatments. This trend is fueled by rising awareness of antibiotic resistance and the demand for organic poultry products.
• Innovation in Formulations: The market is witnessing significant innovations in drug formulations, including the development of new delivery systems and combination therapies. These advancements aim to enhance the efficacy of existing products while minimizing the risk of resistance development among coccidia.
• Increased R&D Investment: Pharmaceutical companies are ramping up their research and development efforts to discover novel anticoccidial agents. This trend is driven by the need for more effective solutions and the desire to comply with stricter regulations regarding drug use in livestock.
• Focus on Animal Welfare: Growing awareness of animal welfare issues is prompting producers to adopt more humane farming practices. This shift influences the development of anticoccidials that not only improve health outcomes for poultry but also align with ethical considerations.
• Regulatory Changes: Stricter regulatory frameworks concerning drug usage and safety are emerging globally. These changes compel manufacturers to enhance their product safety profiles and develop more sustainable and effective anticoccidial solutions to meet compliance requirements.

The anticoccidial drug market is undergoing transformative changes characterized by a move toward natural products, innovative formulations, increased research investment, a focus on animal welfare, and evolving regulatory landscapes. These trends not only address current market demands but also pave the way for a more sustainable and effective approach to managing coccidiosis in livestock.

Recent Developments in the Anticoccidial Drug Market

The anticoccidial drug market is evolving in response to growing challenges such as antibiotic resistance, changing consumer preferences, and stricter regulations. Key players are investing in research and development to create more effective and sustainable solutions. As the demand for poultry products increases globally, advancements in formulations and a focus on animal welfare are shaping the landscape. Understanding these recent developments is crucial for stakeholders aiming to navigate the complexities of the market and adapt to emerging trends.

• New Drug Approvals: Recent approvals of novel anticoccidial agents have expanded the market, providing poultry producers with more options to combat coccidiosis. These new products often feature improved efficacy and safety profiles, meeting the demand for alternatives to traditional treatments.
• Enhanced Combination Therapies: The use of combination therapies has gained traction, as they offer synergistic effects against various strains of coccidia. By combining multiple active ingredients, these formulations enhance effectiveness while reducing the likelihood of resistance, making them increasingly popular among producers.
• Focus on Resistance Management: Addressing antibiotic resistance has become a priority in the anticoccidial market. New strategies, such as rotating different classes of anticoccidials and integrating non-pharmaceutical interventions, are being developed to mitigate resistance and maintain treatment efficacy.
• Integration of Technology: Advancements in technology, including precision agriculture and data analytics, are influencing the anticoccidial market. Producers are utilizing these tools to optimize dosing regimens and monitor health outcomes, leading to more efficient use of anticoccidials and better flock management.
• Emphasis on Sustainable Practices: The growing emphasis on sustainability is driving the development of eco-friendly anticoccidials. Companies are increasingly focusing on plant-based formulations and reducing environmental impact, aligning their products with consumer preferences for sustainable and ethically produced food.

The anticoccidial drug market is experiencing significant developments marked by new drug approvals, enhanced combination therapies, a focus on resistance management, the integration of technology, and an emphasis on sustainable practices. These advancements not only respond to current challenges but also position the industry for future growth, ultimately benefiting producers and consumers alike.

Strategic Growth Opportunities for Anticoccidial Drug Market

The anticoccidial drug market is poised for significant growth as global poultry production continues to rise, driven by increasing protein demand. This dynamic landscape presents numerous strategic opportunities for industry players. Innovations in formulations, a shift toward sustainable practices, and growing consumer awareness about animal welfare are reshaping market dynamics. By capitalizing on these trends, companies can enhance their market position and meet evolving customer needs, making it essential to identify and pursue strategic growth opportunities.

• Expansion into Emerging Markets: There is substantial potential for growth in emerging markets where poultry production is on the rise. Companies can explore partnerships and distribution channels in regions like Southeast Asia and Africa to tap into increasing demand for anticoccidial drugs, boosting sales and market share.
• Development of Novel Formulations: Investing in research and development to create novel formulations can differentiate products in a crowded market. By focusing on innovative delivery systems and combination therapies, companies can enhance efficacy and reduce resistance, catering to producers looking for advanced solutions to coccidiosis.
• Focus on Preventive Health Solutions: As the industry shifts toward preventive health strategies, anticoccidial drugs that integrate into holistic management programs present a significant opportunity. Developing products that support overall flock health while targeting coccidiosis can attract producers seeking comprehensive solutions.
• Collaboration with Technology Providers: Forming partnerships with technology firms can enhance product offerings through data-driven insights and precision agriculture techniques. Integrating these technologies into anticoccidial solutions can improve dosing accuracy and flock monitoring, ultimately leading to better health outcomes and increased sales.
• Sustainable Product Development: Emphasizing sustainability in product development can align with consumer preferences and regulatory demands. Creating eco-friendly, plant-based anticoccidials can not only capture market interest but also position companies as leaders in sustainable agriculture, driving long-term growth.

The anticoccidial drug market presents several strategic growth opportunities, including expansion into emerging markets, the development of novel formulations, a focus on preventive health solutions, collaboration with technology providers, and sustainable product development. By pursuing these avenues, companies can enhance their competitive edge, respond to evolving market needs, and secure a robust position in this rapidly changing industry.

Anticoccidial Drug Market Driver and Challenges

The anticoccidial drug market is experiencing significant transformation, driven by various factors that influence production practices and consumer demand. As global poultry consumption rises, the need for effective solutions to combat coccidiosis becomes increasingly critical. However, this market also faces challenges such as regulatory pressures and shifting consumer preferences. Understanding both the drivers and challenges is essential for stakeholders aiming to navigate the complexities of this evolving landscape and capitalize on growth opportunities.

The factors responsible for driving the anticoccidial drug market include:

• Rising Poultry Production: The increasing demand for poultry products is a primary driver of the anticoccidial drug market. As populations grow and diets shift toward higher protein consumption, poultry producers seek effective solutions to ensure animal health and productivity, leading to greater demand for anticoccidials.
• Growing Awareness of Animal Health: There is a heightened focus on animal welfare and health among consumers and producers alike. This awareness drives the adoption of effective anticoccidial drugs, as stakeholders aim to maintain flock health and productivity while ensuring humane farming practices.
• Regulatory Support for Alternatives: Stricter regulations on antibiotic use in livestock are encouraging the development of alternative anticoccidial agents. This shift is prompting manufacturers to invest in innovative solutions that comply with new guidelines, further driving growth in the market.
• Technological Advancements: Innovations in drug formulations and delivery systems are enhancing the efficacy of anticoccidials. Advances in research and technology allow for the development of products that minimize resistance, making them more appealing to producers seeking effective treatments.
• Increased Investment in R&D: The rising focus on research and development is driving innovation in the anticoccidial market. Companies are investing in the discovery of new active ingredients and combination therapies, which not only meet current demands but also position them competitively for the future.

Challenges in the anticoccidial drug market are:

• Regulatory Challenges: The evolving regulatory landscape poses significant challenges for manufacturers. Compliance with stringent safety and efficacy standards can slow down product development timelines and increase costs, complicating market entry for new products.
• Market Saturation: As the market grows, increased competition among existing players can lead to market saturation. This saturation may drive down prices and squeeze profit margins, making it difficult for companies to maintain sustainable growth.
• Consumer Preference Shifts: Changing consumer preferences toward organic and antibiotic-free products can challenge traditional anticoccidial strategies. Producers may need to adapt their practices to meet these preferences, requiring investment in new, compliant solutions.

In conclusion, the anticoccidial drug market is driven by rising poultry production, growing awareness of animal health, regulatory support for alternatives, technological advancements, and increased investment in R&D. However, challenges such as regulatory hurdles, market saturation, and shifting consumer preferences must be addressed. Understanding these dynamics will help stakeholders navigate the complexities of the market and seize growth opportunities.

List of Anticoccidial Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies anticoccidial drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the anticoccidial drug companies profiled in this report include-

• Zoetis
• Phibro Animal Health Corporation
• Huvepharma
• Elanco
• Biochem Pharma
• Ceva
• Impextraco
• Virbac
• Boehringer Ingelheim International
• MSD Animal Health

Anticoccidial Drug by Segment

The study includes a forecast for the global anticoccidial drug market by animal, drug action, drug class, distribution channel, and region.

Anticoccidial Drug Market by Animal [Analysis by Value from 2019 to 2031]:

• Livestock Animals
• Companion Animals

Anticoccidial Drug Market by Drug Action [Analysis by Value from 2019 to 2031]:

• Coccidiostatic
• Coccidiocidal

Anticoccidial Drug Market by Drug Class [Analysis by Value from 2019 to 2031]:

• Ionophore
• Antibiotic
• Sulphonamides
• Chemical Derivative
• Others

Anticoccidial Drug Market by Distribution Channel [Analysis by Value from 2019 to 2031]:

• Veterinary Hospitals
• Retail Pharmacy
• Others

Anticoccidial Drug Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Anticoccidial Drug Market

The anticoccidial drug market is witnessing significant advancements driven by increasing poultry production, rising awareness of animal health, and regulatory changes. Key players are focusing on innovative formulations and alternative therapies to combat drug resistance and improve efficacy. Countries like the United States, China, Germany, India, and Japan are experiencing varied developments influenced by local market demands, regulatory frameworks, and agricultural practices. Understanding these regional dynamics can provide insights into the ultimate trajectory of the global anticoccidial market.

• United States: The U.S. market is seeing a shift toward natural and organic anticoccidials, driven by consumer demand for antibiotic-free poultry. Regulatory bodies are also encouraging alternatives to traditional chemicals to enhance animal welfare.
• China: Rapid growth in poultry farming has prompted Chinese companies to invest in R&D for new anticoccidial agents, focusing on improving efficacy and reducing side effects. Government support for innovative agriculture further boosts these initiatives.
• Germany: In Germany, stringent regulations on antibiotic use are prompting the development of new anticoccidial drugs with lower resistance profiles. Research institutions collaborate with pharmaceutical companies to enhance product safety and effectiveness.
• India: The Indian anticoccidial market is expanding due to increasing poultry consumption and investment in animal health. Local manufacturers are developing cost-effective solutions while also exploring herbal and alternative treatments.
• Japan: The Japanese market is characterized by advanced formulations that aim to reduce environmental impact. The focus on sustainability drives the development of plant-based anticoccidials, aligning with consumer preferences for eco-friendly products.

Features of the Global Anticoccidial Drug Market

Market Size Estimates: Anticoccidial drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Anticoccidial drug market size by various segments, such as by animal, drug action, drug class, distribution channel, and region in terms of value ($B).

Regional Analysis: Anticoccidial drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different animals, drug actions, drug classes, distribution channels, and regions for the anticoccidial drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the anticoccidial drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the anticoccidial drug market by animal (livestock animals and companion animals), drug action (coccidiostatic and coccidiocidal), drug class (ionophore, antibiotic, sulphonamides, chemical derivative, and others), distribution channel (veterinary hospitals, retail pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Anticoccidial Drug Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Anticoccidial Drug Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Anticoccidial Drug Market by Animal
  • 3.3.1: Livestock Animals
  • 3.3.2: Companion Animals
• 3.4: Global Anticoccidial Drug Market by Drug Action
  • 3.4.1: Coccidiostatic
  • 3.4.2: Coccidiocidal
• 3.5: Global Anticoccidial Drug Market by Drug Class
  • 3.5.1: Ionophore
  • 3.5.2: Antibiotic
  • 3.5.3: Sulphonamides
  • 3.5.4: Chemical Derivative
  • 3.5.5: Others
• 3.6: Global Anticoccidial Drug Market by Distribution Channel
  • 3.6.1: Veterinary Hospitals
  • 3.6.2: Retail Pharmacy
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Anticoccidial Drug Market by Region
• 4.2: North American Anticoccidial Drug Market
  • 4.2.1: North American Market by Animal: Livestock Animals and Companion Animals
  • 4.2.2: North American Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others
• 4.3: European Anticoccidial Drug Market
  • 4.3.1: European Market by Animal: Livestock Animals and Companion Animals
  • 4.3.2: European Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others
• 4.4: APAC Anticoccidial Drug Market
  • 4.4.1: APAC Market by Animal: Livestock Animals and Companion Animals
  • 4.4.2: APAC Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others
• 4.5: ROW Anticoccidial Drug Market
  • 4.5.1: ROW Market by Animal: Livestock Animals and Companion Animals
  • 4.5.2: ROW Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Anticoccidial Drug Market by Animal
  • 6.1.2: Growth Opportunities for the Global Anticoccidial Drug Market by Drug Action
  • 6.1.3: Growth Opportunities for the Global Anticoccidial Drug Market by Drug Class
  • 6.1.4: Growth Opportunities for the Global Anticoccidial Drug Market by Distribution Channel
  • 6.1.5: Growth Opportunities for the Global Anticoccidial Drug Market by Region
• 6.2: Emerging Trends in the Global Anticoccidial Drug Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Anticoccidial Drug Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Anticoccidial Drug Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Zoetis
• 7.2: Phibro Animal Health Corporation
• 7.3: Huvepharma
• 7.4: Elanco
• 7.5: Biochem Pharma
• 7.6: Ceva
• 7.7: Impextraco
• 7.8: Virbac
• 7.9: Boehringer Ingelheim International
• 7.10: MSD Animal Health